VIROPHARMA INC
VPHM
VPHM was delisted on the 23rd of January, 2014.
172 hedge funds and large institutions have $3.29B invested in VIROPHARMA INC in 2013 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 47 increasing their positions, 61 reducing their positions, and 69 closing their positions.
175% more funds holding in top 10
Funds holding in top 10: 4 → 11 (+7)
14% more capital invested
Capital invested by funds: $2.87B → $3.29B (+$416M)
10% less funds holding
Funds holding: 191 → 172 (-19)
23% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 61
25% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 69
57% less call options, than puts
Call options by funds: $67.1M | Put options by funds: $155M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$137M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$127M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
+$120M |
| 4 |
WIC
Water Island Capital
New York
|
+$111M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$92.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$220M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$189M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$188M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$125M |
| 5 |
PC
PointState Capital
New York
|
-$87M |
VPHM Hedge Fund Activity: Q4 2013 in Review
172 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in VIROPHARMA INC (VPHM) for Q4 2013, worth a combined $3.29B — up 14% from $2.87B a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of VPHM and 52 opened new positions — a net loss of 17 holders — while 61 trimmed existing stakes and 47 added.
The largest buyer was Oxford Asset Management, opening a new position worth an estimated $137M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $220M sold.
- 172 institutional investors held VIROPHARMA INC (VPHM) as of Q4 2013, down from 191 in Q3 2013.
- Funds reported $3.29B of VIROPHARMA INC stock for Q4 2013, up 14% quarter-over-quarter.
- 52 funds opened new VIROPHARMA INC positions in Q4 2013 and 69 closed out, a net change of -17 holders.
- The largest VIROPHARMA INC buyer in Q4 2013 was Oxford Asset Management, an estimated $137M added.
- The largest VIROPHARMA INC seller in Q4 2013 was Baker Bros. Advisors, an estimated $220M sold.
Based on aggregated 13F filings for Q4 2013.